Back
EHRA Premium Access

Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Session: Anticoagulation for non-valvular atrial fibrillation in 2017
Topic: Anticoagulation
Speaker: Associate Professor M. Chelu (Houston, US)
Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

About the speaker

Associate Professor Mihail Chelu

Baylor College of Medicine, Houston (United States of America)
3 presentations
0 follower

3 more presentations in this session

What is the correct definition of “non-valvular” atrial fibrillation?

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Access
Slides
Video
Thumbnail

Permanent atrial fibrillation with CHADS-VASC score= 1: nothing, aspirin or anticoagulate?

Speaker: Associate Professor A. Niessner (Vienna, AT)

Access
Slides
Video
Thumbnail

Anticoagulant should NOT be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Speaker: Doctor A. Natale (Austin, US)

Access
Slides
Video
Thumbnail

Access the full session

Anticoagulation for non-valvular atrial fibrillation in 2017

Speakers: Associate Professor M. Chelu, Associate Professor T. Potpara, Associate Professor A. Niessner, Doctor A. Natale
Access
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb